We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Completion of Human Clinical Trial for New Biopharmaceutical

News   May 27, 2011

 
Completion of Human Clinical Trial for New Biopharmaceutical
 
 
Advertisement
 

RELATED ARTICLES

Adhesive Patch Delivers Blood Vessel-Forming Factors to Damaged Tissues

News

A research team has bioengineered a novel adhesive patch platform that can efficiently deliver blood vessel-forming growth factors using a bio-adhesive material that is made from mussels harmless to humans.

READ MORE

Personalized Cancer Vaccine Shows Early Efficacy in Patients With Diverse Tumor Types

News

Treatment with the neoantigen cancer vaccine PGV-001 following standard-of-care adjuvant therapy was well tolerated and demonstrated potential clinical benefit in patients with diverse tumor types according to a Phase 1 study. The findings were reported during the virtual AACR Annual Meeting 2021.

READ MORE

Tacking Treatment-Resistant Fungus With New Formulation of Existing Drugs

News

Researchers have discovered a formulation of existing medicines that can significantly reduce the presence of the fungus Candida auris on skin, controlling its spread and potentially keeping it from forming infections that have a high mortality rate.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE